NZ616160A - Veterinary pharmaceutical formulations and methods - Google Patents
Veterinary pharmaceutical formulations and methods Download PDFInfo
- Publication number
- NZ616160A NZ616160A NZ616160A NZ61616012A NZ616160A NZ 616160 A NZ616160 A NZ 616160A NZ 616160 A NZ616160 A NZ 616160A NZ 61616012 A NZ61616012 A NZ 61616012A NZ 616160 A NZ616160 A NZ 616160A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methyl
- veterinary
- formulation
- oxopentanoate
- methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- WEFZXWJJPHGTTN-UHFFFAOYSA-N methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate Chemical compound COC(=O)C(C)CCC(=O)N(C)C WEFZXWJJPHGTTN-UHFFFAOYSA-N 0.000 abstract 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical compound C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 abstract 1
- OEDUIFSDODUDRK-UHFFFAOYSA-N 5-phenyl-1h-pyrazole Chemical compound N1N=CC=C1C1=CC=CC=C1 OEDUIFSDODUDRK-UHFFFAOYSA-N 0.000 abstract 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 1
- 108010002156 Depsipeptides Proteins 0.000 abstract 1
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 abstract 1
- 229940123925 Nicotinic receptor agonist Drugs 0.000 abstract 1
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 abstract 1
- 150000008361 aminoacetonitriles Chemical class 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000507 anthelmentic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- VJDZMZAZDFKMSV-UHFFFAOYSA-N benzene-1,2-disulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1S(N)(=O)=O VJDZMZAZDFKMSV-UHFFFAOYSA-N 0.000 abstract 1
- -1 chloronicotinyl Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- 239000000181 nicotinic agonist Substances 0.000 abstract 1
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 abstract 1
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 abstract 1
- 239000002728 pyrethroid Substances 0.000 abstract 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 abstract 1
- 229950000975 salicylanilide Drugs 0.000 abstract 1
- 150000007659 semicarbazones Chemical class 0.000 abstract 1
- 229930185156 spinosyn Natural products 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed is a method of veterinary treatment, the method including the step of administration of a formulation including: at least one veterinary pharmaceutical compound selected from any one or more of: a macrocyclic lactone, an anthelmintic nicotinic receptor agonist, an amino-acetonitrile derivative, an imidazothiazole, a benzimidazole, a spirodioxepinoindole, a salicylanilide, a benzenedisulfonamide, a spinosyn, a chloronicotinyl, a pyrethrin, a synthetic pyrethroid, an organophosphate, a carbamate, a formamidine, a phenylpyrazole, a semicarbazone; a cyclic depsipeptide, an anti-inflammatory, analgesic, ntiemetic an antihyperthyroid, an antihypothyroid; and methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate. Also disclosed is a veterinary formulation and a method of producing a veterinary formulation comprising methyl 5-(dimethylamino)-2-methyl-5-oxopentanoate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ616160A NZ616160A (en) | 2012-09-28 | 2012-09-28 | Veterinary pharmaceutical formulations and methods |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ616160A NZ616160A (en) | 2012-09-28 | 2012-09-28 | Veterinary pharmaceutical formulations and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ616160A true NZ616160A (en) | 2014-06-27 |
Family
ID=58408311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ616160A NZ616160A (en) | 2012-09-28 | 2012-09-28 | Veterinary pharmaceutical formulations and methods |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ616160A (en) |
-
2012
- 2012-09-28 NZ NZ616160A patent/NZ616160A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX339968B (en) | Parasiticidal compositions comprising multiple active agents, methods and uses thereof. | |
| ZA201608614B (en) | Solid oral pharmaceutical compositions for isoxazoline compounds | |
| MX2022010831A (en) | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof. | |
| WO2013100566A8 (en) | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same | |
| WO2013114371A8 (en) | Dry powder formulations of dnase i | |
| WO2015048757A3 (en) | Foam formulations and apparatus for delivery | |
| MX2021004439A (en) | Oral solid formulation containing irinotecan and method of preparing the same. | |
| WO2011005052A8 (en) | Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same | |
| WO2014060638A8 (en) | A veterinary method of alleviating noise aversion | |
| WO2014020405A8 (en) | Cyclic urea- or lactam-substituted quinoxaline-type piperidine compounds and the uses thereof | |
| MX363699B (en) | Co-micronisation product comprising ulipristal acetate. | |
| NZ622869A (en) | Stable veterinary anthelmintic formulations | |
| CA2817001A1 (en) | Methods for inhibiting insect infestations | |
| NZ616160A (en) | Veterinary pharmaceutical formulations and methods | |
| EP2722322A4 (en) | 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient | |
| MX2015001137A (en) | Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad. | |
| EP3697381C0 (en) | Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof | |
| PH12014501384A1 (en) | Antibiotic formulations | |
| WO2010029093A3 (en) | Compositions for percutaneous administration | |
| MX2016011310A (en) | Endoparasite control agent. | |
| WO2014184248A3 (en) | Trpa1 antagonist compounds | |
| NZ594610A (en) | Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants | |
| WO2012041286A3 (en) | Device for injecting an active ingredient | |
| MX2016011308A (en) | Endoparasite control agent. | |
| EP3010534A4 (en) | Pharmaceutical formulations and methods for oral delivery of biologically active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2018 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20170925 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2019 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20180927 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2020 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20190930 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2021 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20200902 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2022 BY AJ PARK Effective date: 20210910 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2023 BY AJ PARK Effective date: 20220901 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 OCT 2024 BY AJ PARK Effective date: 20230911 |